Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey
Background Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision to...
Saved in:
Published in | European journal of pain Vol. 25; no. 10; pp. 2177 - 2189 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.11.2021
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!